Pyridostigmine Bromide
- Product NDC
- 69238-1731
- 11-digit product format
- 692381731
- Labeler code
- 69238
- Product ID
- 69238-1731_c11900df-97bb-47f5-8a29-05fe1586d556
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pyridostigmine Bromide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA212702
- Marketing category
- ANDA
- Marketing start
- 2020-01-17
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/5mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 60 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903843 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69238-1731-2 | Pyridostigmine Bromide | 473 mL in 1 BOTTLE | SOLUTION | 473 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1731 | PYRIDOSTIGMINE BROMIDE SOLUTION [AMNEAL PHARMACEUTICALS NY LLC] | 8 | Current NDC, Legacy NDC, 1 package rows | 20240404_9c3a5abf-e217-4292-a305-5afd12b99e95.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1731-2 | 69238173102 | 473 mL in 1 BOTTLE (69238-1731-2) | 473 ml | 2020-01-17 | 0000-00-00 | No | No | Current |